Delighted to announce that o2h discovery will be exhibiting at the ElRIG UK’s annual conference Drug Discovery 2021 on 19th – 20th Oct.
2020 was a year of challenge, but it was also a turning point for our industry, as our community came together and was at the forefront of the scientific effort to overcome and manage the COVID virus. Together we made unprecedented scientific progress, which we will recognize and celebrate at Drug Discovery 2021.
ELRIG’s annual Drug Discovery meeting is still Europe’s largest meeting for life sciences industry professionals and will return in the autumn of 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the period of the pandemic. For more information, please visit – https://www.elrig.org/portfolio/drug-discovery-2021/
o2h discovery is a Contract Research Organization providing FTE drug discovery services through its capabilities to support biological target validation, hit finding, hit expansion, hit to lead, lead optimization and pre-clinical scale-up programs leading to novel IP and IND filing from its state-of-the-art research center in Ahmedabad, India and Mill SciTech Park in Cambridge, UK.
Claudio Dagostin and Andy Morley will be representing o2h discovery at the event and they would be delighted to discuss how our service offerings can support your drug discovery programme.
To meet with us during or after the event, please contact claudio@o2h.com. You can also meet us virtually at our booth using this link.
